Lineage Cell Therapeutics
LCTX
#7567
Rank
ยฃ0.29 B
Marketcap
ยฃ1.28
Share price
14.29%
Change (1 day)
131.20%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2025 (TTM): -ยฃ15.53 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are ยฃ10.81 Million. In 2024 the company made an earning of -ยฃ15.66 Million, an increase over its 2023 earnings that were of -ยฃ18.04 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ15.53 Million-0.89%
2024 -ยฃ15.66 Million-13.16%
2023 -ยฃ18.04 Million9.83%
2022 -ยฃ16.42 Million-54.24%
2021 -ยฃ35.88 Million86.07%
2020 -ยฃ19.29 Million-31.97%
2019 -ยฃ28.35 Million-5.42%
2018 -ยฃ29.97 Million1.1%
2017 -ยฃ29.65 Million-31.06%
2016 -ยฃ43 Million-10.38%
2015 -ยฃ47.98 Million29.69%
2014 -ยฃ37 Million31.68%
2013 -ยฃ28.1 Million
2011 -ยฃ13.64 Million89.78%
2010 -ยฃ7.19 Million206.06%
2009 -ยฃ2.35 Million-0.58%
2008 -ยฃ2.37 Million164.89%
2007 -ยฃ0.9 Million-30.22%
2006 -ยฃ1.28 Million
2002 -ยฃ1.49 Million-41.04%
2001 -ยฃ2.52 Million-32.04%
2000 -ยฃ3.71 Million-11.85%
1999 -ยฃ4.2 Million
1997 -ยฃ2.7 Million12.12%
1996 -ยฃ2.41 Million106.25%
1995 -ยฃ1.17 Million-11.11%
1994 -ยฃ1.32 Million50%
1993 -ยฃ0.88 Million20%
1992 -ยฃ0.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-ยฃ0.11 Billion 627.71%๐Ÿ‡บ๐Ÿ‡ธ USA